References
- KnightKWadeSBalducciLPrevalence and outcomes of anemia in cancer: A systematic review of the literatureAm J Med20041161126
- DicatoMPlawnyLDiederichMAnemia in cancerAnn Oncol201021Suppl 7vii167vii17220943610
- National Compreensive Cancer NetworkCancer- and Chemotherapy-Induced Anemia. Version 2201711162016 https://www.nccn.org/professionals/physician_gls/pdf/anemia.pdfAccessed January 3, 2018
- LudwigHProfMüldürEEndlerGHüblWPrevalence of iron deficiency across different tumors and its association with poor performance status, disease status and anemiaAnn Oncol20132471886189223567147
- GilreathJAStenehjemDDRodgersGMDiagnosis and treatment of cancer-related anemiaAm J Hematol201489220321224532336
- ToniaTMettlerARobertNErythropoietin or darbepoetin for patients with cancerCochrane Database Syst Rev20121212CD00340723235597
- Norma da Direção-Geral da Saúde. Abordagem, Diagnóstico e Tratamento da Ferropénia no Adulto [Portuguese Directorate-General of Health norm on approach, diagnosis and treatment of iron deficiency in adults] number 030/2013; revised April 9, 2015. Available from: https://www.dgs.pt/?cr=25229Accessed January 3, 2018 Portuguese
- SantiagoPFerrous versus ferric oral iron formulations for the treatment of iron deficiency: a clinical overviewScientificWorldJournal2012201284682422654638
- GeisserPBanké-BochitaJPharmacokinetics, safety and tolerability of intravenous ferric carboxymaltose: a dose-escalation study in volunteers with mild iron-deficiency anaemiaArzneimittelforschung2011606362372
- FunkFRylePCancliniCNeiserSGeisserPThe new generation of intravenous iron: chemistry, pharmacology, and toxicology of ferric carboxymaltoseArzneimittelforschung2010606a34535320648926
- SteinmetzTTschechneBHarlinOClinical experience with ferric carboxymaltose in the treatment of cancer- and chemotherapy-associated anaemiaAnn Oncol201324247548223071262
- VerhaegheLBruyneelLStragierEFerranteMDierickxDPrenenHThe effectiveness of intravenous iron for iron deficiency anemia in gastrointestinal cancer patients: a retrospective studyAnn Gastroenterol201730665466329118560
- LebrunFKlasterskyJLevacqDWissamYPaesmansMIntravenous iron therapy for anemic cancer patients: a review of recently published clinical studiesSupport Care Cancer20172572313231928386789
- GemiciCYetmenOYaprakGIs there any role of intravenous iron for the treatment of anemia in cancer?BMC Cancer20161666127542823
- KeatingGMFerric carboxymaltose: a review of its use in iron deficiencyDrugs201575110112725428711
- CalvetXRuízMÀDosalACost-minimization analysis favours intravenous ferric carboxymaltose over ferric sucrose for the ambulatory treatment of severe iron deficiencyPLoS One201279
- ToledanoALuporsiEMorereJFClinical use of ferric carboxymaltose in patients with solid tumours or haematological malignancies in FranceSupport Care Cancer2016241677525921449
- Ferinject (ferric carboxymaltose) [summary of prescribing information]Vifor Pharma UK Limited Available from: https://www.medicines.org.uk/emc/medicine/24167/SPC/Ferinject+(ferric+carboxymaltose)/Accessed July 5, 2018
- CallejaJLDelgadoSdel ValAFerric carboxymaltose reduces transfusions and hospital stay in patients with colon cancer and anemiaInt J Colorectal Dis201631354355126694926
- CellaDThe longitudinal relationship of hemoglobin, fatigue and quality of life in anemic cancer patients: results from five randomized clinical trialsAnn Oncol200415697998615151958
- KeelerBDSimpsonJANgSThe feasibility and clinical efficacy of intravenous iron administration for preoperative anaemia in patients with colorectal cancerColor Dis20141610794800
- ParkSJungCWJangJHIntravenous Iron Supplementation Alone for Treatment of Anemia in Cancer PatientsBlood2017130Suppl 14756